Gulinac M et al (2023) Long-term effectiveness, outcomes and complications of bariatric surgery. World J Clin Cases 11(19):4504–4512
Steenackers N et al (2021) Adaptations in gastrointestinal physiology after sleeve gastrectomy and Roux-en-Y gastric bypass. Lancet Gastroenterol Hepatol 6(3):225–237
Angrisani L et al (2024) IFSO worldwide survey 2020–2021: current trends for bariatric and metabolic procedures. Obes Surg 34(4):1075–1085
Reges O et al (2018) Association of bariatric surgery using laparoscopic banding, Roux-en-Y gastric bypass, or laparoscopic sleeve gastrectomy vs usual care obesity management with all-cause mortality. JAMA 319(3):279–290
Peterli R et al (2018) Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA 319(3):255–265
Moffett RC, Docherty NG, le Roux CW (2021) The altered enteroendocrine reportoire following roux-en-Y-gastric bypass as an effector of weight loss and improved glycaemic control. Appetite 156:104807
Moreira S et al (2023) Roux-en-Y gastric bypass improves adiponectin to leptin ratio and inflammatory profile in severely obese women with and without metabolic syndrome: a randomized controlled trial. Nutrients 15(15):3312
Nussbaumerova B, Rosolova H (2023) Obesity and dyslipidemia. Curr Atheroscler Rep 25(12):947–955
Bilen O, Virani S, Nambi V (2018) Chapter 42—hyperlipidemia. In: Levine GN (ed) Cardiology secrets, 5th edn. Elsevier, Amsteradm, pp 377–386
To VT et al (2012) Changes in body weight, glucose homeostasis, lipid profiles, and metabolic syndrome after restrictive bariatric surgery. Exp Clin Endocrinol Diabetes 120(9):547–552
De Luca M et al (2023) Metabolic bariatric surgery as a therapeutic option for patients with type 2 diabetes: a meta-analysis and network meta-analysis of randomized controlled trials. Diabetes Obes Metab 25(8):2362–2373
Carswell KA et al (2016) A systematic review and meta-analysis of the effect of gastric bypass surgery on plasma lipid levels. Obes Surg 26(4):843–855
Heffron SP et al (2016) Changes in lipid profile of obese patients following contemporary bariatric surgery: a meta-analysis. Am J Med 129(9):952–959
Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration
Wells GA et al (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
Gleysteen JJ (1992) Results of surgery: long-term effects on hyperlipidemia. Am J Clin Nutr 55(2 Suppl):591s–593s
Ortega J et al (2004) Vertical banded gastroplasty converted to Roux-en-Y gastric bypass: little impact on nutritional status after 5-year follow-up. Obes Surg 14(5):638–643
Kligman MD et al (2008) Shrinking cardiovascular risk through bariatric surgery: application of Framingham risk score in gastric bypass. Surgery 143(4):533–538
Jamal M et al (2011) Resolution of hyperlipidemia follows surgical weight loss in patients undergoing Roux-en-Y gastric bypass surgery: a 6-year analysis of data. Surg Obes Relat Dis 7(4):473–479
Suter M et al (2011) Laparoscopic Roux-En-Y gastric bypass: significant long-term weight loss, improvement of obesity-related comorbidities and quality of life. Ann Surg 254(2):267–273
Aminian A et al (2014) Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass. Surg Obes Relat Dis 10(4):576–582
Dogan K et al (2014) Long-term effects of laparoscopic Roux-en-Y gastric bypass on diabetes mellitus, hypertension and dyslipidaemia in morbidly obese patients. Obes Surg 24(11):1835–1842
Ties JS et al (2014) The effect of laparoscopic gastric bypass on dyslipidemia in severely obese patients: a 5-year follow-up analysis. Obes Surg 24(4):549–553
Bhasker AG et al (2015) Predictors of remission of T2DM and metabolic effects after laparoscopic Roux-en-y gastric bypass in obese Indian diabetics-a 5-year study. Obes Surg 25(7):1191–1197
Pajecki D et al (2015) Bariatric surgery in the elderly: results of a mean follow-up of five years. ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 28:15–18
Gómez-Abril S et al (2016) Short- and long-term effects of weight loss on the complement component C3 after laparoscopic gastric bypass in obese patients. Obes Surg 26(11):2756–2763
Shah K et al (2016) Long-term effects of laparoscopic Roux-en-Y gastric bypass on metabolic syndrome in patients with morbid obesity. Surg Obes Relat Dis 12(8):1449–1456
Silva CF et al (2016) Effects of long-term Roux-en-Y gastric bypass on body weight and clinical metabolic comorbidities in Bariatric surgery service of a University Hospital. Arq Bras Cir Dig 29:20–23
Adams TD et al (2017) Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med 377(12):1143–1155
Øvrebø B et al (2017) Bariatric surgery versus lifestyle interventions for severe obesity: 5-year changes in body weight, risk factors and comorbidities. Clin Obes 7(3):183–190
Shah AS et al (2017) Lipid changes 8 years post gastric bypass in adolescents with severe obesity (FABS-5+ study). Int J Obes (Lond) 41(10):1579–1584
Sundbom M et al (2017) Substantial decrease in comorbidity 5 years after gastric bypass: a population-based study from the Scandinavian obesity surgery registry. Ann Surg 265(6):1166–1171
Climent E et al (2018) Changes in the lipid profile 5 years after bariatric surgery: laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy. Surg Obes Relat Dis 14(8):1099–1105
Gero D et al (2018) Laparoscopic Roux-En-Y gastric bypass improves lipid profile and decreases cardiovascular risk: a 5-year longitudinal cohort study of 1048 patients. Obes Surg 28(3):805–811
Ikramuddin S et al (2018) Lifestyle intervention and medical management with vs without Roux-en-Y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the diabetes surgery study. JAMA 319(3):266–278
Magno F et al (2018) Long term maintenance of glucose and lipid concentrations after Roux-en-Y gastric bypass. Arch Endocrinol Metab 62(3):346–351
Mônaco-Ferreira DV et al (2018) Metabolic changes up to 10 years after gastric bypass. Obes Surg 28(6):1636–1642
Minhem MA, Alami RS, Safadi BY (2019) Long-term outcomes of diabetes after laparoscopic Roux-en-Y gastric bypass in a Lebanese bariatric practice. Int J Diabetes Dev Ctries 39(4):611–617
Nonino CB et al (2019) Is there any change in phenotypic characteristics comparing 5 to 10 years of follow-up in obese patients undergoing Roux-en-Y gastric bypass? Arq Bras Cir Dig 32(3):e1453
Pereira LMC et al (2019) Assessment of cardiometabolic risk factors physical activity levels, and quality of life in stratified groups up to 10 years after bariatric surgery. Int J Environ Res Public Health 16(11):1975
Cunha JB et al (2020) Clinical and metabolic improvement after bariatric surgery in older adults: a 6-year follow-up. J Nutr Health Aging 24(8):865–869
Ji G et al (2020) Effect of Roux-en-Y gastric bypass for patients with type 2 diabetes mellitus and a BMI < 32.5 kg/m2: a 6-year study in Chinese patients. Obes Surg 30(7):2631–2636
Mantziari S et al (2020) Long-term weight loss, metabolic outcomes, and quality of life at 10 years after Roux-en-Y gastric bypass are independent of patients’ age at baseline. Obes Surg 30(4):1181–1188
Rodríguez-Álvarez C et al (2020) Metabolic syndrome after Roux-en-Y gastric bypass in patients with morbid obesity: five years of follow-up, a before and after study. Int J Surg 74:5–10
Voglino C et al (2020) Cardiovascular benefits and lipid profile changes 5 years after bariatric surgery: a comparative study between sleeve gastrectomy and Roux-en-Y gastric bypass. J Gastrointest Surg 24(12):2722–2729
Goday A et al (2021) Bariatric surgery improves metabolic and nonalcoholic fatty liver disease markers in metabolically healthy patients with morbid obesity at 5 years. Surg Obes Relat Dis 17(12):2047–2053
Comments (0)